Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (P20GM103421)
Text and Data Mining valid from 2019-11-01
Received: 8 January 2019
Accepted: 4 September 2019
First Online: 1 November 2019
Ethics approval and consent to participate
: This study was approved by the ethics committees of Lifespan Medical Center (467617–9) and Women Infants Hospital (797108–3). The need for consent was waived by the IRB.
: Not applicable.
: Y.W, A. S. B and M. B. R. declare that a patent application has been approved 7/2017 titled as COLLAGENS AS MARKERS FOR BREAST CANCER TREATMENT to ASB, YW and MBR of Rhode Island Hospital, A Lifespan-Partner (Application No. 15/187,279). No potential conflicts of interest were disclosed by other authors.